Microsoft (NASDAQ:MSFT) remains a titan in the tech industry. It is known for its iconic Windows operating system, Office productivity suite and Xbox gaming platform. However, in recent years, the company has undergone a remarkable transformation, shifting its focus toward cloud computing and emerging technologies. Now, its Azure cloud platform and strong presence in the
0 Comments
Since I’m severely lactose, I eat many plant-based foods and drink many plant-based beverages. The data suggests that many other Americans, whether because of lactose intolerance or for other reasons, eat plant-based foods and drink plant-based beverages. Indeed, “The (United States) plant-based food market surged from $3.9 billion in 2017 to $8.1 billion in 2023,”
0 Comments
Market volatility can often be a goldmine for savvy investors looking to snap up undervalued growth stocks at bargain prices. The broader market has seen significant appreciation in 2024, driven largely by the technology sector. Yet, certain stocks have remained underpriced despite maintaining solid fundamentals and great growth prospects. As the market continues its upward
0 Comments
The stock market is starting to lose steam. After a record run, equities have turned sharply lower over the past few weeks. The reasons are various including geopolitical worries, a financial shock in Japan, changes in the U.S. presidential election race and uncertainty around interest rate policy. Regardless of the precise cause, market volatility has
0 Comments
For any other company, the CrowdStrike (NASDAQ:CRWD) debacle might have spelled doom. But, as always, Microsoft (NASDAQ:MSFT) stock has risen like a Phoenix from the so-called ashes. It demonstrates impressive resilience no matter how challenging the market conditions are. Or the fallouts from various unpleasant events. Three key drivers – a dominant subscription business model,
0 Comments
A man walks past Kobayashi Pharmaceutical’s headquarters building in Osaka on April 2, 2024. Yuichi Yamazaki | AFP | Getty Images Company: Kobayashi Pharmaceutical (4967.T) Business: Kobayashi Pharmaceutical manufactures and sells pharmaceuticals and consumer products in Japan and internationally. The company operates in three segments: The Domestic Business and International Business segments offer health care,
0 Comments
For many investors, the conversation around the semiconductor industry isn’t always the clearest. Some companies are fabricators, others are designers, and then there’s Arm Holdings (NASDAQ:ARM) which is a designer for designers, which puts ARM stock in an interesting position. That’s because Arm sells the chipset instructions for some of the most sought-after designs for
0 Comments
Thanks to the inclusion of artificial intelligence elements in the iPhone, which is predicted to become the next major revenue generator for the tech behemoth, Apple (NASDAQ:AAPL) stock stays a consistent performer. Apple is a fascinating investment because of its constant innovation, great financial success, and measured market growth. Apple’s market share, technical innovation, and
0 Comments
Those holding REITs have seen their portfolios lag behind in recent years, with the sector struggling under the weight of rising interest rates. The current economic climate has been particularly harsh on REITs, which are feeling the strain from increased borrowing costs and a shift in investor preference towards safer fixed-income assets. In particular, with
0 Comments
The trade in technology stocks is getting more difficult. The mega-cap tech names known collectively as the “Magnificent Seven” lost a combined $1 trillion of value amid the global market rout that occurred on August 5. Chipmaker Nvidia (NASDAQ:NVDA) lost $168 billion in market capitalization as its stock fell 6.4%, while Apple (NASDAQ:AAPL) and Amazon
0 Comments